Home Archive by category NEWS DESK (Page 518)

NEWS DESK

Get the latest press releases on menew247.com. Direct from the source, we bring you official announcements, statements, and news from key industries and government entities across the Middle East. Stay informed with real-time updates on launches, events, and strategic initiatives.

NEWS DESK

Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase

Promega Corporation has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase. Designed for enhanced accuracy and sensitivity in RNA analysis, the enzyme will enhance Promega capabilities to manufacture and deliver both catalog and customized solutions for clinical, applied and pharmaceutical molecular
NEWS DESK

Experian Ranked 6th in 2025 IDC FinTech Rankings: Top 100

Experian today announced that it was ranked 6th in the 2025 IDC FinTech Rankings: Top 100, rising one spot from last year’s rankings and placing in the top-10 global technology providers for the fourth consecutive year. The FinTech Rankings feature enterprise companies from around the world that serve multiple industries and generate significant revenues from the
NEWS DESK

The UAE Sports Science and Sports Medicine Center launches the Professional Diploma in Sports Management and Analytics to enhance national sports capabilities

In line with its efforts to develop a new generation of national talents in sports management, the UAE Sports Science and Sports Medicine Center – under the patronage of the Ministry of Sports – has announced the launch of the Professional Diploma in Sports Management and Analytics in collaboration with the UAE Committee for Talent […]
NEWS DESK

Lilly’s Verzenio® (abemaciclib) increases overall survival in HR+, HER2-, high-risk early breast cancer with two years of therapy

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the primary overall survival (OS) analysis of the Phase 3 monarchE trial. Treatment with two years of Verzenio plus endocrine therapy (ET) demonstrated a statistically significant and clinically meaningful improvement in OS compared to ET alone in patients with hormone receptor positive
NEWS DESK

CE-Invests Joins $50 Million Funding Round for Flipspaces

CE-Invests, the strategic investments platform of Crescent Enterprises, today announced its participation in the $50 million Series C funding round for Flipspaces, a leading tech-first interior design and build company for commercial spaces operating across India and the USA. Flipspaces has experienced significant momentum since its incorporation in 2015. Its proprietary